EN PL
SHORT COMMUNICATION
Polymyositis, dermatomyositis and inclusion body myositis
 
More details
Hide details
 
Online publication date: 2012-06-01
 
 
Reumatologia 2012;50(2):119-123
 
KEYWORDS
ABSTRACT
Idiopathic inflammatory myopathy is a group of diseases of unknown aetiology and probably autoimmune pathogenesis (Tables I, II). Treatment of the diseases is divided into the following stages: initial phase, intermediate phase, and long-lasting therapy. Glucocorticoids and other immunosuppressive drugs (commonly azathioprine and methotrexate) are applied for management. It is important to evaluate activity of the disease, effectiveness of the treatment and occurrence of adverse reactions. Inclusion body myositis is resistant to glucocorticoid therapy.
 
REFERENCES (6)
1.
Lundberg IE, Vencovsky J, Dani L. Polymyositis, dermatomyositis, inflammatory diseases of muscles and other myopathies. In: EULAR Compendium. Bijlsma JW, et al. (eds.). BMJ, London 2009: 297-313.
 
2.
Kucharz EJ. Idiopatyczna miopatia zapalna. W: Reumatologia. Wielka interna. Puszczewicz M (red.). Medical Tribune Polska, Warszawa 2010; 148-156.
 
3.
Hengstma GJ, van den Hoogen FH, van Engelen BG. Treatment of the inflammatory myopathies: update and practical recommendations. Expert Opin Pharmacother 2009; 10: 1183-1190.
 
4.
Chwalińska-Sadowska H, Małdykowa H. Polymyositis – dermatomyositis: 25 years of follow-up of 50 patients disease course, treatment, prognostic factors. Mater Med Pol 1990; 22: 213-218.
 
5.
Kucharz EJ. Zapalenie mięśni z ciałkami wtrętowymi. Pol Arch Med Wewn 1998; 100: 262-266.
 
6.
Kucharz EJ. Dziedziczna miopatia z ciałkami wtrętowymi. Przegl Lek 1999; 56: 735-738.
 
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
eISSN:2084-9834
ISSN:0034-6233
Journals System - logo
Scroll to top